Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1995
A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitorsB S Youn, I K Jang, H E Broxmeyer, et al.
Virus Genes|January 10, 2002
Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stressJ M Hill, W J Lukiw, B M Gebhardt, et al.
Current Cancer Drug Targets|August 25, 2011
H⁺-myo-inositol transporter SLC2A13 as a potential marker for cancer stem cells in an oral squamous cell carcinomaD G Lee, J-H Lee, B K Choi, et al.
Clinical and Experimental Immunology|January 18, 2006
Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitisP Maerten, B S Kwon, C Shen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 10, 1998
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorptionB S Kwon, S Wang, N Udagawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3B S Youn, S M Zhang, E K Lee, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 7, 2004
Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survivalH R Cho, B Kwon, H Yagita, et al.
The Journal of Biological Chemistry|May 30, 1997
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activationB S Kwon, K B Tan, J Ni, et al.
The Journal of Clinical Investigation|September 17, 1998
LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transferY Zhai, R Guo, T L Hsu, et al.
Nature Communications|September 21, 2017
Predictors of responses to immune checkpoint blockade in advanced melanomaN Jacquelot, M P Roberti, D P Enot, et al.
Pageof 12